Recurrent herpes simplex: the outlook for systemic antiviral agents.
D000212:Acyclovir; D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use*; D001973:Bromodeoxyuridine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005814:Genes, Viral / Q000187:drug effects; D006147:Guanine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006561:Herpes Simplex / Q000517:prevention & control*; D006801:Humans; D051379:Mice; D012008:Recurrence; D018139:Simplexvirus / Q000201:enzymology; D013937:Thymidine Kinase / Q000378:metabolism; D014779:Virus Replication / Q000187:drug effects
D000998:Antiviral Agents; C020235:brivudine; D006147:Guanine; D013937:Thymidine Kinase; D001973:Bromodeoxyuridine; D000212:Acyclovir